Trial Profile
A Trial of the Safety, Tolerability and Efficacy of 2 Doses of Cayston (Aztreonam Lysine) Compared to Placebo in Participants With Bronchiectasis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2023
Price :
$35
*
At a glance
- Drugs Aztreonam (Primary)
- Indications Bronchiectasis
- Focus Adverse reactions
- Acronyms VitalBE
- 13 Apr 2023 Planned End Date changed from 30 Jun 2022 to 30 Sep 2025.
- 13 Apr 2023 Planned primary completion date changed from 30 Jun 2022 to 30 Sep 2025.
- 13 Apr 2023 Status changed from active, no longer recruiting to recruiting.